This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
SARS | 3185 |
COVID-19 | 1732 |
CoV-2 | 1328 |
CoV | 616 |
China | 445 |
mg | 441 |
Coronavirus | 378 |
kg | 339 |
ICU | 333 |
T | 320 |
ACE2 | 312 |
ARDS | 273 |
IL-6 | 250 |
B | 239 |
CT | 238 |
Wuhan | 231 |
IV | 229 |
HBV | 222 |
RNA | 221 |
IFN | 209 |
MERS | 198 |
Disease | 197 |
C | 197 |
Syndrome | 183 |
• | 181 |
PCR | 179 |
Health | 174 |
II | 155 |
TNF | 154 |
EA | 141 |
S | 140 |
FDA | 135 |
Table | 135 |
Respiratory | 134 |
L | 131 |
A | 120 |
HE | 118 |
DIC | 118 |
CD4 | 116 |
MBL | 114 |
Clinical | 114 |
World | 111 |
CNS | 109 |
NK | 108 |
CRP | 105 |
J | 101 |
Hospital | 101 |
CoV-1 | 99 |
HIV | 97 |
Organization | 96 |
Kong | 96 |
Hong | 96 |
α | 95 |
Treatment | 95 |
HRS | 95 |
B. | 94 |
M | 92 |
H1N1 | 92 |
Care | 92 |
United | 91 |
CD8 | 89 |
meta | 88 |
Novel | 83 |
RT | 82 |
Patients | 82 |
PICU | 80 |
IQR | 80 |
ECMO | 80 |
East | 79 |
Africa | 79 |
< | 79 |
Study | 78 |
States | 76 |
Plasmodium | 75 |
CI | 75 |
PIDD | 74 |
Association | 74 |
D | 72 |
US | 71 |
IL-10 | 71 |
P. | 70 |
sha | 69 |
IgG | 69 |
USA | 68 |
LPS | 68 |
Human | 67 |
HPS | 67 |
Middle | 66 |
March | 66 |
Europe | 66 |
ALF | 66 |
III | 65 |
IgM | 64 |
WHO | 64 |
L. | 63 |
IVIG | 63 |
Fig | 63 |
TMPRSS2 | 63 |
− | 62 |
CSF | 62 |
Group | 61 |
Box | 60 |
May | 59 |
lymphopenia | 58 |
tocilizumab | 57 |
UK | 55 |
Pneumonia | 55 |
PO | 55 |
ACLF | 54 |
anakinra | 54 |
South | 54 |
hepatitis | 53 |
New | 53 |
Asia | 53 |
γ | 52 |
National | 52 |
K | 52 |
F | 52 |
ECG | 52 |
Virus | 51 |
Remdesivir | 51 |
RD | 51 |
Influenza | 51 |
Analysis | 50 |
I | 50 |
Intensive | 50 |
University | 50 |
Therapy | 49 |
medRxiv | 48 |
Society | 48 |
LDH | 48 |
Kupffer | 48 |
Kawasaki | 48 |
HLA | 48 |
January | 47 |
Italy | 47 |
Covid-19 | 47 |
Pediatric | 47 |
Prevention | 47 |
Tocilizumab | 46 |
Children | 46 |
Candida | 45 |
CPB | 45 |
C. | 45 |
Singapore | 44 |
S. | 44 |
Control | 44 |
SFTSV | 43 |
RBD | 43 |
IL-1 | 43 |
CRS | 42 |
America | 42 |
Article | 42 |
Hydroxychloroquine | 42 |
Management | 42 |
hydroxychloroquine | 42 |
ritonavir | 41 |
Staphylococcus | 41 |
Severe | 41 |
Protein | 41 |
Japan | 41 |
DOI | 41 |
April | 41 |
U | 40 |
AECHB | 40 |
M. | 40 |
Evaluation | 40 |
Use | 40 |
azithromycin | 40 |
~ | 40 |
pH | 39 |
Review | 39 |
RDS | 39 |
JAK | 39 |
Diseases | 39 |
Characteristics | 39 |
CLF | 39 |
West | 38 |
PCT | 38 |
Medical | 38 |
Li | 38 |
December | 37 |
February | 37 |
Ill | 37 |
Borrelia | 37 |
H5N1 | 37 |
Medicine | 37 |
July | 37 |
SBP | 37 |
Unit | 37 |
Wang | 37 |
remdesivir | 37 |
HCO | 36 |
Canada | 36 |
American | 36 |
HLH | 36 |
monocyte | 36 |
Lopinavir | 35 |
HCQ | 35 |
Development | 35 |
Drug | 34 |
BCAA | 34 |
Center | 34 |
Convalescent | 34 |
Critical | 34 |
Th17 | 34 |
Plasma | 34 |
Research | 34 |
SFTS | 34 |
alfa | 34 |
GABA | 33 |
CHB | 33 |
DC | 33 |
DNA | 33 |
Department | 33 |
Efficacy | 33 |
HSR | 33 |
IL-8 | 33 |
IgA | 33 |
International | 33 |
Trial | 33 |
IL-17 | 33 |
bronchoalveolar | 33 |
BAL | 32 |
HPA | 32 |
AUC | 32 |
Asthma | 32 |
Grade | 32 |
CDC | 32 |
IgE | 32 |
Korea | 32 |
SIRS | 32 |
Willebrand | 32 |
lopinavir | 32 |
S1 | 31 |
Na | 31 |
Malaria | 31 |
Infection | 31 |
GM | 31 |
EMA | 31 |
CVP | 31 |
COVID | 31 |
BMI | 31 |
APACHE | 31 |
CAP | 30 |
COPD | 30 |
Chloroquine | 30 |
Assessment | 30 |
Accepted | 30 |
Cell | 30 |
Neutrophil | 30 |
Distress | 30 |
European | 30 |
Leptospira | 30 |
drotrecogin | 30 |
Report | 30 |
E. | 30 |
IL-1β | 29 |
CD14 | 29 |
CRI | 29 |
Diagnosis | 29 |
Ebola | 29 |
IP-10 | 29 |
Immune | 29 |
Laboratory | 29 |
MODS | 29 |
N | 29 |
Viral | 29 |
India | 28 |
Acute | 28 |
E | 28 |
Emergency | 28 |
IM | 28 |
von | 28 |
PT | 28 |
Spike | 28 |
WBC | 28 |
artesunate | 28 |
sera | 28 |
AST | 27 |
IL-2 | 27 |
Antibody | 27 |
CMV | 27 |
CoV. | 27 |
Hepatitis | 27 |
Huang | 27 |
SQ | 27 |
Infectious | 27 |
June | 27 |
Lyme | 27 |
R. | 27 |
malaria | 27 |
J. | 27 |
R | 26 |
ADE | 26 |
BP | 26 |
BY | 26 |
CXCL10 | 26 |
D. | 26 |
Risk | 26 |
TB | 26 |
TLR4 | 26 |
Zhou | 26 |
Zika | 26 |
anterior | 26 |
ALT | 25 |
APTT | 25 |
CC | 25 |
Chinese | 25 |
Detection | 25 |
Effect | 25 |
IL-4 | 25 |
RBC | 25 |
mRNA | 25 |
q8h | 25 |
thrombocytopenia | 25 |
NC | 25 |
IL-13 | 24 |
AG | 24 |
AT | 24 |
Administration | 24 |
Global | 24 |
Guangdong | 24 |
Institute | 24 |
Leishmania | 24 |
MRI | 24 |
Ringer | 24 |
X. | 24 |
ND | 23 |
Angiotensin | 23 |
BCG | 23 |
Committee | 23 |
Coronaviruses | 23 |
G. | 23 |
ICUs | 23 |
LA | 23 |
Factor | 23 |
North | 23 |
RSV | 23 |
Rickettsia | 23 |
Transmission | 23 |
Vietnam | 23 |
X | 23 |
fi | 23 |
multicentre | 23 |
PRISM | 23 |
Figure | 22 |
Liu | 22 |
IR | 22 |
IL | 22 |
ABO | 22 |
Case | 22 |
Brazil | 22 |
ACT | 22 |
Lung | 22 |
Liver | 22 |
PTA | 22 |
MD | 22 |
Network | 22 |
Ritonavir | 22 |
SLF | 22 |
System | 22 |
Taiwan | 22 |
Toronto | 22 |
VIII | 22 |
administration | 22 |
± | 22 |
ATP | 21 |
Adults | 21 |
Antiviral | 21 |
Australia | 21 |
Bartonella | 21 |
CA | 21 |
Cochrane | 21 |
Receptor | 21 |
S2 | 21 |
Zhang | 21 |
MELD | 21 |
Effectiveness | 20 |
A. | 20 |
AP | 20 |
CHF | 20 |
CM | 20 |
CO | 20 |
CP | 20 |
CS | 20 |
Data | 20 |
EAACI | 20 |
ELISA | 20 |
Dimer | 20 |
Fisher | 20 |
Lancet | 20 |
France | 20 |
Province | 20 |
Pathogenesis | 20 |
Nile | 20 |
Meta | 20 |
Y. | 20 |
INR | 20 |
Host | 20 |
Germany | 20 |
G | 20 |
MV | 19 |
ALI | 19 |
Acanthamoeba | 19 |
Anakinra | 19 |
CLD | 19 |
City | 19 |
College | 19 |
EPA | 19 |
Epidemiology | 19 |
HFO | 19 |
Hg | 19 |
Hospitalized | 19 |
amoxicillin | 19 |
Mortality | 19 |
T4 | 19 |
Tregs | 19 |
VII | 19 |
Yang | 19 |
York | 19 |
adefovir | 19 |
inflammasome | 19 |
interleukin-6 | 19 |
PSS | 19 |
mandrillaris | 19 |
Central | 18 |
Community | 18 |
Chest | 18 |
Chen | 18 |
8) | 18 |
CPAP | 18 |
COVID‐19 | 18 |
Anti | 18 |
ACE-2 | 18 |
IRs | 18 |
Fc | 18 |
Molecular | 18 |
Interferon | 18 |
MAP | 18 |
NF | 18 |
Outcomes | 18 |
Q | 18 |
_ | 18 |
airways | 18 |
inotropic | 18 |
tickborne | 18 |
LV | 18 |
CoVs | 17 |
Inhibition | 17 |
HMGB1 | 17 |
Guidelines | 17 |
First | 17 |
Early | 17 |
Balamuthia | 17 |
Cardiac | 17 |
CPCR | 17 |
Bz | 17 |
NKT | 17 |
BS | 17 |
AAA | 17 |
MOF | 17 |
IETM | 17 |
NO | 17 |
dl | 17 |
Pulmonary | 17 |
omalizumab | 17 |
nan | 17 |
mm | 17 |
mL | 17 |
min | 17 |
der | 17 |
Y | 17 |
Thrombocytopenia | 17 |
September | 17 |
Response | 17 |
ROC | 17 |
G6PD | 16 |
Med | 16 |
Kingdom | 16 |
I. | 16 |
Hubei | 16 |
H20 | 16 |
H | 16 |
Beijing | 16 |
ESR | 16 |
EGDT | 16 |
Creative | 16 |
Comparative | 16 |
Commons | 16 |
Chronic | 16 |
PCV | 16 |
PA | 16 |
Gene | 16 |
PD | 16 |
Surveillance | 16 |
× | 16 |
azole | 16 |
Zheng | 16 |
Vaccine | 16 |
Type | 16 |
Text | 16 |
Public | 16 |
Safety | 16 |
SNP | 16 |
SMO | 16 |
SD | 16 |
Republic | 16 |
Randomized | 16 |
≤ | 16 |
CVD | 15 |
GFR | 15 |
GDV | 15 |
Dysregulation | 15 |
DR | 15 |
Critically | 15 |
Cl | 15 |
Cancer | 15 |
Blood | 15 |
CFR | 15 |
C3 | 15 |
Baricitinib | 15 |
BCCA | 15 |
Arbidol | 15 |
ACTH | 15 |
Immunology | 15 |
ICP | 15 |
H. | 15 |
MBL2 | 15 |
Ribavirin | 15 |
MNM | 15 |
β | 15 |
tenofovir | 15 |
oliguria | 15 |
mmol | 15 |
anti | 15 |
Supplementary | 15 |
State | 15 |
lymphohistiocytosis | 15 |
PubMed | 15 |
Phase | 15 |
PIP | 15 |
PHT | 15 |
Netherlands | 15 |
Mexico | 15 |
Protease | 15 |
Guangzhou | 14 |
Emerging | 14 |
Entry | 14 |
GenOSept | 14 |
Innate | 14 |
HCV | 14 |
HRCT | 14 |
High | 14 |
EEG | 14 |
Elizabethan | 14 |
Academy | 14 |
Cov-2 | 14 |
CoV2 | 14 |
Centers | 14 |
CGD | 14 |
CCL2 | 14 |
Associated | 14 |
Allergy | 14 |
Activation | 14 |
LOS | 14 |
Ixodes | 14 |
baricitinib | 14 |
Mann | 14 |
TSH | 14 |
® | 14 |
Mediterranean | 14 |
mOsm | 14 |
leucopenia | 14 |
disease | 14 |
association | 14 |
Vero | 14 |
Umifenovir | 14 |
Th2 | 14 |
tPA | 14 |
Systematic | 14 |
Russia | 14 |
Survanta | 14 |
NIV | 14 |
Pyridostigmine | 14 |
NI | 14 |
SALF | 14 |
SIGN | 14 |
Spain | 14 |
NP | 13 |
Findings | 13 |
NL63 | 13 |
Mycoplasma | 13 |
Macrophage | 13 |
MIS | 13 |
Janus | 13 |
IL-12 | 13 |
Full | 13 |
Cytokine | 13 |
Favipiravir | 13 |
Escherichia | 13 |
Ehrlichia | 13 |
EMCO | 13 |
CXR | 13 |
COV-2 | 13 |
CD147 | 13 |
Abstract | 13 |
PaO | 13 |
NSAIDs | 13 |
Paediatric | 13 |
monogenic | 13 |
VEGF | 13 |
Patient | 13 |
μmol | 13 |
| | 13 |
tachypnea | 13 |
lamivudine | 13 |
entecavir | 13 |
dupilumab | 13 |
Whitney | 13 |
XII | 13 |
Thailand | 13 |
Teico | 13 |
TCR | 13 |
Science | 13 |
SEVERE | 13 |
SC | 13 |
SARS‐CoV‐2 | 13 |
Region | 13 |
Pugh | 13 |
Koch | 12 |
IL-18 | 12 |
IL-1ra | 12 |
IRF3 | 12 |
Identification | 12 |
Immunol | 12 |
Impact | 12 |
MCP-1 | 12 |
Legionella | 12 |
Lymphopenia | 12 |
MCD | 12 |
NLRP3 | 12 |
NPA | 12 |
HFOV | 12 |
HIV-1 | 12 |
BW | 12 |
GWAS | 12 |
GA | 12 |
Food | 12 |
Dexamethasone | 12 |
DKA | 12 |
CoV-2-specific | 12 |
Clin | 12 |
COVID19 | 12 |
CO2 | 12 |
Obesity | 12 |
BTK | 12 |
BSs | 12 |
Azithromycin | 12 |
Appendix | 12 |
Anaplasma | 12 |
OC43 | 12 |
PLR | 12 |
October | 12 |
fingolimod | 12 |
W. | 12 |
Wei | 12 |
Wu | 12 |
XIII | 12 |
Organ | 12 |
endotypes | 12 |
glucocorticosteroids | 12 |
Toll | 12 |
hepatorenal | 12 |
iv | 12 |
ml | 12 |
multiorgan | 12 |
syndrome | 12 |
κB | 12 |
Valentine | 12 |
Zhao | 12 |
Thoracic | 12 |
Rule | 12 |
Tang | 12 |
PROWESS | 12 |
Pandemic | 12 |
Primaquine | 12 |
Pseudomonas | 12 |
Panton | 12 |
SPSS | 12 |
SaO | 12 |
Shock | 12 |
Streptococcus | 12 |
Structure | 12 |
PD-1 | 12 |
Features | 11 |
DHA | 11 |
Diagnostic | 11 |
ESR1 | 11 |
Ethics | 11 |
Factors | 11 |
IMCI | 11 |
Fi02 | 11 |
Genome | 11 |
Guideline | 11 |
HDL | 11 |
Heparin | 11 |
Corticosteroids | 11 |
Cryptococcus | 11 |
IX | 11 |
Cohort | 11 |
ClinicalTrials.gov | 11 |
Chlamydia | 11 |
CD3 | 11 |
CD16 | 11 |
Bunyavirus | 11 |
Background | 11 |
Authorization | 11 |
Adenovirus | 11 |
AIDS | 11 |
ACh | 11 |
ABD | 11 |
3a | 11 |
IU | 11 |
Artesunate | 11 |
Illness | 11 |
Susceptibility | 11 |
Immunoglobulin | 11 |
umifenovir | 11 |
thromboplastin | 11 |
serovar | 11 |
preprint | 11 |
p<0.01 | 11 |
neutrophilia | 11 |
meningoencephalitis | 11 |
cm | 11 |
chloroquine | 11 |
antiphospholipid | 11 |
analysis | 11 |
TLRs | 11 |
rt | 11 |
Southeast | 11 |
NLR | 11 |
Rapid | 11 |
Infections | 11 |
Johnson | 11 |
MTX | 11 |
N. | 11 |
MHC | 11 |
Novartis | 11 |
Pediatrics | 11 |
RCT | 11 |
ROS | 11 |
RV | 11 |
ET | 10 |
HCoV | 10 |
English | 10 |
Equine | 10 |
Failure | 10 |
Fas | 10 |
Fluid | 10 |
Fontan | 10 |
Fusion | 10 |
GSK | 10 |
Interleukin-6 | 10 |
HI | 10 |
HRTV | 10 |
Hb | 10 |
Hypokalemia | 10 |
IL-5 | 10 |
Inflammatory | 10 |
Intravenous | 10 |
K. | 10 |
LPV | 10 |
Dr. | 10 |
E6 | 10 |
Arabia | 10 |
Deng | 10 |
CTL | 10 |
-5 | 10 |
-6 | 10 |
2C | 10 |
AHRF | 10 |
ANP | 10 |
Ab | 10 |
Abs | 10 |
MAC | 10 |
Bunyaviridae | 10 |
CVVH | 10 |
De | 10 |
Cardiovascular | 10 |
Cells | 10 |
Chi | 10 |
Coagulopathy | 10 |
Collaborative | 10 |
Complement | 10 |
Coronaviridae | 10 |
Corticosteroid | 10 |
Cox | 10 |
London | 10 |
Heart | 10 |
MAS | 10 |
Sepsis | 10 |
Statistical | 10 |
TBK1 | 10 |
Testing | 10 |
Thrombosis | 10 |
Tim-3 | 10 |
Von | 10 |
Working | 10 |
XI | 10 |
anuria | 10 |
herpes | 10 |
hyphema | 10 |
infl | 10 |
miss | 10 |
nivolumab | 10 |
rifaximin | 10 |
ruxolitinib | 10 |
siltuximab | 10 |
type-1 | 10 |
van | 10 |
MCP-3 | 10 |
vivo | 10 |
Southern | 10 |
Yu | 10 |
Saudi | 10 |
P<0.001 | 10 |
Mycobacterium | 10 |
Retrospective | 10 |
NGAL | 10 |
NTM | 10 |
Natural | 10 |
November | 10 |
OPN | 10 |
Observational | 10 |
Open | 10 |
P | 10 |
NEU | 10 |
PAI-1 | 10 |
PVL | 10 |
Release | 10 |
People | 10 |
Palpate | 10 |
Prediction | 10 |
PTSD | 10 |
PIMS | 10 |
PE | 10 |
IL-9 | 9 |
Ju | 9 |
IL6 | 9 |
Inhibitors | 9 |
Initiative | 9 |
Interleukin-1 | 9 |
Intravascular | 9 |
Introduction | 9 |
Joint | 9 |
Journal | 9 |
Mayo | 9 |
Ltd. | 9 |
MEE | 9 |
MILD | 9 |
Hepatopulmonary | 9 |
Melioidosis | 9 |
Merkel | 9 |
Mice | 9 |
Michigan | 9 |
Mountain | 9 |
Multisystem | 9 |
NHIS | 9 |
IL-15 | 9 |
AMI | 9 |
Heartland | 9 |
Glasgow | 9 |
NO2 | 9 |
Agency | 9 |
Airway | 9 |
Americans | 9 |
Amoy | 9 |
BBB | 9 |
CDH | 9 |
CPR | 9 |
CQ | 9 |
Crohn | 9 |
DAD | 9 |
David | 9 |
Diao | 9 |
Drosten | 9 |
EN | 9 |
ETT | 9 |
England | 9 |
FV | 9 |
FiO | 9 |
GAE | 9 |
GBS | 9 |
NICU | 9 |
cmH20 | 9 |
Naegleria | 9 |
Twenty | 9 |
Vet | 9 |
Xu | 9 |
Xue | 9 |
anesthesia | 9 |
benralizumab | 9 |
borreliosis | 9 |
hemophagocytic | 9 |
hepatosplenomegaly | 9 |
ivermectin | 9 |
lebrikizumab | 9 |
mepolizumab | 9 |
p<0.05 | 9 |
pHi | 9 |
plasmin | 9 |
protein | 9 |
q6h | 9 |
series | 9 |
tid | 9 |
transjugular | 9 |
~s | 9 |
Nipah | 9 |
V | 9 |
mmHg | 9 |
Treg | 9 |
RR | 9 |
OLT | 9 |
Time | 9 |
PK | 9 |
PLTC | 9 |
PPQ | 9 |
PR | 9 |
Phlebovirus | 9 |
Pract | 9 |
Publisher | 9 |
PS | 9 |
Roche | 9 |
Severity | 9 |
Summary | 9 |
Sweden | 9 |
T. | 9 |
TNFα | 9 |
TPO | 9 |
Ray | 9 |
Tab | 9 |
Tan | 9 |
ER | 8 |
Force | 8 |
Gao | 8 |
GS-5734 | 8 |
Front | 8 |
Free | 8 |
F. | 8 |
Finland | 8 |
FPG | 8 |
FCH | 8 |
Elastikon | 8 |
Golgi | 8 |
Gardens | 8 |
Institutional | 8 |
Gong | 8 |
Guinea | 8 |
HBsAg | 8 |
HC | 8 |
HCC | 8 |
Hypoglycaemia | 8 |
ICS | 8 |
Index | 8 |
Inhibitor | 8 |
Jean | 8 |
Lee | 8 |
MAPK | 8 |
Dysregulated | 8 |
EM | 8 |
AKBR | 8 |
Doppler | 8 |
Brain | 8 |
MI | 8 |
-1 | 8 |
24h | 8 |
ACE | 8 |
ADA | 8 |
AM | 8 |
AOAH | 8 |
African | 8 |
Age | 8 |
Americas | 8 |
BALF | 8 |
Babesia | 8 |
Broad | 8 |
Dis | 8 |
CAZ | 8 |
CCI | 8 |
CD26 | 8 |
CHD | 8 |
Cao | 8 |
Centre | 8 |
ChAdOx1 | 8 |
Child | 8 |
Complex | 8 |
Consensus | 8 |
Creactive | 8 |
Dengue | 8 |
MDA | 8 |
Inc. | 8 |
Martin | 8 |
T2 | 8 |
Terriers | 8 |
Texas | 8 |
Tracheal | 8 |
U.S. | 8 |
V. | 8 |
VKBR | 8 |
VL | 8 |
Veterinary | 8 |
Vetrap | 8 |
Western | 8 |
XLA | 8 |
Zhi | 8 |
author(s | 8 |
azotemia | 8 |
bunyavirus | 8 |
dexamethasone | 8 |
etanercept | 8 |
fl | 8 |
henselae | 8 |
hyperimmune | 8 |
i | 8 |
neutrophilic | 8 |
pOR | 8 |
parasitemia | 8 |
rheumatoid | 8 |
ribavirin | 8 |
Monocyte | 8 |
Team | 8 |
burnetii | 8 |
Surface | 8 |
Procalcitonin | 8 |
Sun | 8 |
Multicentre | 8 |
NT | 8 |
Neisseria | 8 |
Northern | 8 |
PEEP | 8 |
PFC | 8 |
PH | 8 |
PLV | 8 |
PSI | 8 |
Pre | 8 |
Predictors | 8 |
Ò | 8 |
RA | 8 |
SSC | 8 |
Studies | 8 |
Shenzhen | 8 |
Service | 8 |
Serologic | 8 |
Scale | 8 |
Series | 8 |
SNLI | 8 |
SCID | 8 |
Royal | 8 |
Reference | 8 |
RdRp | 8 |
Injury | 7 |
Havemeyer | 7 |
IL-7 | 7 |
IFA | 7 |
ICH | 7 |
Hu | 7 |
Henan | 7 |
Hemophagocytic | 7 |
General | 7 |
HPLC | 7 |
Guidance | 7 |
Gordon | 7 |
Glucocorticoids | 7 |
Foundation | 7 |
GCS | 7 |
Investigation | 7 |
Interactions | 7 |
Manifestations | 7 |
Kendall | 7 |
LBRF | 7 |
Fallot | 7 |
Mechanism | 7 |
Maria | 7 |
Manual | 7 |
MUF | 7 |
MTB | 7 |
MR | 7 |
MAVS | 7 |
MA | 7 |
Lymphohistiocytosis | 7 |
Lymphocyte | 7 |
Long | 7 |
Lombardy | 7 |
Lectin | 7 |
Labrador | 7 |
Fever | 7 |
ANF | 7 |
FSE | 7 |
Enzyme | 7 |
BCP | 7 |
Attribution | 7 |
AstraZeneca | 7 |
Aspergillus | 7 |
Artemether | 7 |
Aedes | 7 |
Activity | 7 |
Access | 7 |
Meplazumab | 7 |
ALSS | 7 |
AIT | 7 |
AI | 7 |
ADH | 7 |
ACEI | 7 |
A2 | 7 |
BNP | 7 |
Bili | 7 |
Board | 7 |
DNR | 7 |
ECLS | 7 |
Dupilumab | 7 |
Doxycycline | 7 |
Dong | 7 |
Da | 7 |
DTT | 7 |
Coagulation | 7 |
British | 7 |
CVC | 7 |
CSS | 7 |
CPT | 7 |
COVID-2019 | 7 |
CAVH | 7 |
Bruton | 7 |
Mechanisms | 7 |
Guan | 7 |
Ming | 7 |
clavulanate | 7 |
hetastarch | 7 |
hemothorax | 7 |
haematocrit | 7 |
glucocorticosteroid | 7 |
factorV | 7 |
count | 7 |
coryza | 7 |
capnometry | 7 |
Urbani | 7 |
cGMP | 7 |
asthma | 7 |
arthralgia | 7 |
airway | 7 |
Yuan | 7 |
Wilcoxon | 7 |
VSD | 7 |
https://doi.org/10.1101/2020.05.24.20111864 | 7 |
infi | 7 |
inhibitor-1 | 7 |
injectate | 7 |
Missouri | 7 |
und | 7 |
thrombocytopathia | 7 |
therapy | 7 |
st | 7 |
simplex | 7 |
quintana | 7 |
q6 | 7 |
p=0.001 | 7 |
nAbs | 7 |
myelofibrosis | 7 |
lymphocytopenia | 7 |
lavage | 7 |
kcal | 7 |
interferon | 7 |
VM | 7 |
primaquine | 7 |
Union | 7 |
Program | 7 |
Potential | 7 |
Physiology | 7 |
Pacific | 7 |
PTT | 7 |
PTE | 7 |
PSV | 7 |
PRIMS | 7 |
PMN | 7 |
PAI | 7 |
Origin | 7 |
ORF | 7 |
OI | 7 |
Nacional | 7 |
Task | 7 |
Model | 7 |
Practice | 7 |
Organisation | 7 |
Retrievers | 7 |
Switzerland | 7 |
Rocky | 7 |
Target | 7 |
TLR | 7 |
TISS | 7 |
TGA | 7 |
TEG | 7 |
TLR2 | 7 |
Rotterdam | 7 |
Stage | 7 |
Small | 7 |
Serum | 7 |
Scientific | 7 |
Ruxolitinib | 7 |
Survival | 7 |
LMWH | 6 |
Induction | 6 |
Int | 6 |
Interaction | 6 |
Interleukin | 6 |
Juan | 6 |
Kling | 6 |
Killer | 6 |
Klebsiella | 6 |
Korean | 6 |
Immunogenicity | 6 |
LD | 6 |
LBP | 6 |
Hepatorenal | 6 |
Imaging | 6 |
ISR | 6 |
IEP | 6 |
Humans | 6 |
Huanan | 6 |
Hopkins | 6 |
Hemodynamic | 6 |
Haemostasis | 6 |
Haematological | 6 |
HNF4 | 6 |
HBc | 6 |
GlaxoSmithKline | 6 |
Lavage | 6 |
Glycyrrhizin | 6 |
Lab | 6 |
Mount | 6 |
Le | 6 |
License | 6 |
OR | 6 |
Genomic | 6 |
OPV | 6 |
Nucleocapsid | 6 |
Normosol | 6 |
NSAIDS | 6 |
NPEV | 6 |
NOS | 6 |
NMDA | 6 |
NLP | 6 |
Multicenter | 6 |
Mucosal | 6 |
Ms. | 6 |
Morbidity | 6 |
Monitoring | 6 |
Miniature | 6 |
Methods | 6 |
Membrane | 6 |
Maternal | 6 |
Marburg | 6 |
Mannose | 6 |
Main | 6 |
MIP-2 | 6 |
MEDLINE | 6 |
MDR | 6 |
MASP2 | 6 |
Lu | 6 |
Genotype | 6 |
Baseline | 6 |
Genetic | 6 |
CARD9 | 6 |
Boehringer | 6 |
Binding | 6 |
Benralizumab | 6 |
Bao | 6 |
Bacteroides | 6 |
BDP | 6 |
BDNF | 6 |
August | 6 |
Artemisinin | 6 |
Application | 6 |
Antigenicity | 6 |
Antigen | 6 |
Anim | 6 |
Amikacine | 6 |
Alk | 6 |
Akdis | 6 |
Adult | 6 |
Adolescents | 6 |
ASD | 6 |
ARB | 6 |
AR | 6 |
APS | 6 |
AKI | 6 |
A(H1N1)pdm09 | 6 |
8h | 6 |
3D | 6 |
ORF6 | 6 |
C5 | 6 |
CCL4 | 6 |
GC | 6 |
CD19 | 6 |
Function | 6 |
Fr | 6 |
FRC | 6 |
FHF | 6 |
Expression | 6 |
Epidemiologic | 6 |
Enterococcus | 6 |
Ecuador | 6 |
Eastern | 6 |
Dose | 6 |
Domain | 6 |
Dept | 6 |
DEX | 6 |
DEET | 6 |
Corona | 6 |
Congo | 6 |
Commission | 6 |
Charlson | 6 |
Characterization | 6 |
Cdyn | 6 |
Canadian | 6 |
Ca | 6 |
CXCL9 | 6 |
CXCL8 | 6 |
CVID | 6 |
COVID−19 | 6 |
CD56 | 6 |
ORF1ab | 6 |
SSPE | 6 |
PAF | 6 |
hyperferritinemia | 6 |
miyamotoi | 6 |
microangiopathy | 6 |
methylprednisolone | 6 |
max | 6 |
lung | 6 |
lobular | 6 |
lhe | 6 |
leukocytosis | 6 |
kappaB | 6 |
kB | 6 |
infliximab | 6 |
i.v | 6 |
hyperferritinemic | 6 |
hydrocortisone | 6 |
caval | 6 |
hepatopulmonary | 6 |
hemoglobinuria | 6 |
glycyrrhizin | 6 |
endosomal | 6 |
ehrlichiosis | 6 |
doxycycline | 6 |
des | 6 |
den | 6 |
defensin | 6 |
dL | 6 |
crystalloid | 6 |
covid-19 | 6 |
cephalexin | 6 |
n=6 | 6 |
nucleocapsid | 6 |
nucleoprotein | 6 |
p<.05 | 6 |
μg | 6 |
PAM | 6 |
μL | 6 |
° | 6 |
© | 6 |
vena | 6 |
thrombomodulin | 6 |
thrombocytopaenia | 6 |
terlipressin | 6 |
sulfadiazine | 6 |
square | 6 |
spp | 6 |
range | 6 |
rSO2 | 6 |
qPCR | 6 |
q8 | 6 |
pyothorax | 6 |
protein-1 | 6 |
prerenal | 6 |
plasmacytoid | 6 |
pg | 6 |
parainfluenza | 6 |
pDCs | 6 |
pCO2 | 6 |
p=0.003 | 6 |
p<0.0001 | 6 |
p<0,001 | 6 |
cefazolin | 6 |
pembrolizumab | 6 |
cava | 6 |
TABD | 6 |
Standard | 6 |
Spectrum | 6 |
Sophia | 6 |
Shepherd | 6 |
Saharan | 6 |
SVR | 6 |
STROBE | 6 |
ST | 6 |
SP | 6 |
SNPs | 6 |
SMD | 6 |
SJIA | 6 |
SEM | 6 |
SAVI | 6 |
SAA | 6 |
Robert | 6 |
RAS | 6 |
R0 | 6 |
Qb | 6 |
Primary | 6 |
Phos | 6 |
Pentaglobin | 6 |
Panel | 6 |
PSVP | 6 |
carprofen | 6 |
PRRs | 6 |
PN | 6 |
Student | 6 |
S4 | 6 |
TC | 6 |
Tickborne | 6 |
antigen | 6 |
carboxyhemoglobin | 6 |
antibody | 6 |
TH17 | 6 |
Ying | 6 |
Wales | 6 |
W | 6 |
Vt | 6 |
VVHDF | 6 |
VAS | 6 |
URT | 6 |
U. | 6 |
Tissue | 6 |
Viruses | 6 |
Tian | 6 |
TMPRSS4 | 6 |
Thrombin | 6 |
TNFR1 | 6 |
TP | 6 |
TRAIL | 6 |
Technology | 6 |
TOBRA | 6 |
Th1 | 6 |
Therapeutic | 6 |
Therapies | 6 |
TLR7 | 6 |
Hantavirus | 5 |
Hyperimmune | 5 |
Heat | 5 |
Helicobacter | 5 |
Histoplasma | 5 |
Hotel | 5 |
Healthy | 5 |
Hypoalbuminemia | 5 |
Hyperkalemia | 5 |
Hyphema | 5 |
IC | 5 |
ICAM-1 | 5 |
ID | 5 |
IL)-6 | 5 |
Han | 5 |
IGHV3 | 5 |
IE | 5 |
Hanoi | 5 |
Giamarellos | 5 |
HME | 5 |
Geneva | 5 |
Fang | 5 |
Fatal | 5 |
IL-23 | 5 |
Federal | 5 |
FiO2 | 5 |
Florida | 5 |
Future | 5 |
GCs | 5 |
Gilead | 5 |
HKU1 | 5 |
5 | |
GraphPad | 5 |
Groups | 5 |
Guillain | 5 |
Gülsen | 5 |
H&E | 5 |
H3 | 5 |
H7N9 | 5 |
IL-22 | 5 |
LSTM | 5 |
IL-2R | 5 |
Johnston | 5 |
Kg | 5 |
Kidney | 5 |
LCV | 5 |
LOLA | 5 |
Lactate | 5 |
Levels | 5 |
Lipopolysaccharide | 5 |
Lyu | 5 |
MARS | 5 |
MCA | 5 |
MDA5 | 5 |
MSD | 5 |
MSUD | 5 |
Ma | 5 |
Major | 5 |
Malarone | 5 |
FEV1 | 5 |
Kenya | 5 |
Jia | 5 |
IL-6/8 | 5 |
Jappe | 5 |
IL-6R | 5 |
ILC2 | 5 |
ILI | 5 |
IMV | 5 |
INF | 5 |
INO | 5 |
IRF7 | 5 |
ISTH | 5 |
Induced | 5 |
Ingelheim | 5 |
Insights | 5 |
Institutes | 5 |
Instituto | 5 |
Iran | 5 |
JAK1 | 5 |
JAK2 | 5 |
JNK | 5 |
FVII | 5 |
BIPAP | 5 |
FEV | 5 |
Authority | 5 |
BER | 5 |
BMC | 5 |
Bhanja | 5 |
Bone | 5 |
Bourboulis | 5 |
Branch | 5 |
Brazilian | 5 |
Bronchoalveolar | 5 |
C2 | 5 |
C3b | 5 |
C4 | 5 |
CBC | 5 |
CD36 | 5 |
CD69 | 5 |
CK | 5 |
CNEP | 5 |
CTX | 5 |
BD | 5 |
Atopic | 5 |
FDP | 5 |
Assay | 5 |
Mao | 5 |
-Preliminary | 5 |
3CL | 5 |
A(H1N1 | 5 |
ALB | 5 |
AMG | 5 |
ANOVA | 5 |
AOSD | 5 |
ARF | 5 |
AZ | 5 |
Abbott | 5 |
Aerosol | 5 |
Alvofact | 5 |
Amblyomma | 5 |
Animal | 5 |
Antibodies | 5 |
Apgar | 5 |
Carmalt | 5 |
Cellular | 5 |
Cheng | 5 |
Childhood | 5 |
Du | 5 |
Dysrhythmias | 5 |
E2 | 5 |
EASL | 5 |
EDTA | 5 |
EGFR | 5 |
ELBW | 5 |
EMBASE | 5 |
ERK | 5 |
EV | 5 |
Embolism | 5 |
Enterobacteriaceae | 5 |
Epidemic | 5 |
Epidemiological | 5 |
Erythrocyte | 5 |
Establishment | 5 |
Expert | 5 |
Dr | 5 |
Div | 5 |
Distribution | 5 |
Cross | 5 |
Clinic | 5 |
Coma | 5 |
Comorbidities | 5 |
Conference | 5 |
Consortium | 5 |
Contraindications | 5 |
Costa | 5 |
D3 | 5 |
Discovery | 5 |
DCs | 5 |
DFO | 5 |
DNI | 5 |
DS | 5 |
Daniel | 5 |
Dependent | 5 |
Design | 5 |
Malaysia | 5 |
auris | 5 |
Material | 5 |
a1111111111 | 5 |
aids | 5 |
alfacon-1 | 5 |
bethesdensis | 5 |
borgpetersenii | 5 |
chi | 5 |
corticosteroid | 5 |
cryoprecipitate | 5 |
darunavir | 5 |
dipivoxil | 5 |
doc_id | 5 |
dolasetron | 5 |
doxapram | 5 |
emapalumab | 5 |
epidermodysplasia | 5 |
g.w | 5 |
hematochezia | 5 |
heparin | 5 |
aOR | 5 |
Zhejiang | 5 |
hyperfibrinolysis | 5 |
Z. | 5 |
Test | 5 |
Th-17 | 5 |
Thevarajan | 5 |
Third | 5 |
Transcriptomic | 5 |
Uganda | 5 |
VB | 5 |
VCV | 5 |
Van | 5 |
Virology | 5 |
Washington | 5 |
Wedi | 5 |
Xa | 5 |
Xiang | 5 |
Xin | 5 |
Ye | 5 |
Yi | 5 |
hyperechoic | 5 |
i.c | 5 |
TLR3 | 5 |
polymorphonuclear | 5 |
receptor | 5 |
rhesus | 5 |
rickettsii | 5 |
rst | 5 |
sarilumab | 5 |
scRNAseq | 5 |
sec | 5 |
streptokinase | 5 |
t2 | 5 |
tarsus | 5 |
tbr | 5 |
terbutaline | 5 |
trimethoprim | 5 |
uroabdomen | 5 |
vWF | 5 |
verruciformis | 5 |
Measurement | 5 |
prothrombinase | 5 |
pneumomediastinum | 5 |
immunoassays | 5 |
phagocyte | 5 |
isoproterenol | 5 |
kDa | 5 |
lra | 5 |
lymphopaenia | 5 |
methocarbamol | 5 |
miRNA | 5 |
mid | 5 |
midazolam | 5 |
miltefosine | 5 |
mol | 5 |
nelfinavir | 5 |
neuroimmune | 5 |
ng | 5 |
nicorol | 5 |
oseltamivir | 5 |
p<0,05 | 5 |
perforin | 5 |
TLR9 | 5 |
nvH1N1 | 5 |
TBRF | 5 |
PL | 5 |
PRR | 5 |
Pathology | 5 |
Pathophysiology | 5 |
Patienten | 5 |
Peiris | 5 |
Persistence | 5 |
Pharma | 5 |
Pharmaceutical | 5 |
Pharmacokinetic | 5 |
Plasmalyte | 5 |
Pleural | 5 |
Polymerase | 5 |
Population | 5 |
Precision | 5 |
Preliminary | 5 |
Professor | 5 |
Protection | 5 |
PPE | 5 |
PCO | 5 |
Prothrombin | 5 |
Oxford | 5 |
Medicines | 5 |
TAF | 5 |
Met | 5 |
Mg | 5 |
Molecule | 5 |
Mpro | 5 |
Multi | 5 |
NCPAP | 5 |
NE | 5 |
NETosis | 5 |
NIH | 5 |
NKG2A | 5 |
NO3 | 5 |
NSAID | 5 |
Nafamostat | 5 |
Novalgin | 5 |
ORFs | 5 |
Proteins | 5 |
NS | 5 |
Publishing | 5 |
STAT | 5 |
SW | 5 |
Saint | 5 |
San | 5 |
Sanofi | 5 |
Sat | 5 |
Shi | 5 |
Sinai | 5 |
Song | 5 |
SpO | 5 |
Storm | 5 |
Strategy | 5 |
Stress | 5 |
Structural | 5 |
Sudan | 5 |
Q. | 5 |
Surgical | 5 |
Systemic | 5 |
STING | 5 |
Stem | 5 |
SLUD | 5 |
Replication | 5 |
RDSN | 5 |
Qin | 5 |
SLKT | 5 |
Qian | 5 |
RDTs | 5 |
REE | 5 |
Registry | 5 |
Reinfection | 5 |
Recommendations | 5 |
Resistance | 5 |
Responses | 5 |
Rev | 5 |
Ro | 5 |
SL | 5 |
SAS | 5 |
S3 | 5 |
Hemostasis | 4 |
House | 4 |
Hospitals | 4 |
Hepatic | 4 |
Hamid | 4 |
Hemophilia | 4 |
Heinz | 4 |
Hematologic | 4 |
Helsinki | 4 |
Haven | 4 |
Hypercoagulability | 4 |
Humoral | 4 |
IRF8 | 4 |
IAV | 4 |
ICT | 4 |
IG | 4 |
IL-1α | 4 |
IL10 | 4 |
IPI | 4 |
IVIg | 4 |
IgG1 | 4 |
Immunity | 4 |
Immunopathogenesis | 4 |
Immunosuppression | 4 |
HPT | 4 |
Incidence | 4 |
Integrated | 4 |
HR | 4 |
Frequency | 4 |
HBOCs | 4 |
GATA2 | 4 |
Epithelial | 4 |
Interim | 4 |
Epstein | 4 |
Exosurf | 4 |
FII | 4 |
FLA | 4 |
FX | 4 |
Falciparum | 4 |
Fan | 4 |
Figs | 4 |
French | 4 |
Functional | 4 |
GCSF | 4 |
HAP | 4 |
GGT | 4 |
GMP | 4 |
GST | 4 |
Gavardo | 4 |
Genomewide | 4 |
German | 4 |
Glucocorticoid | 4 |
Glucocorticosteroids | 4 |
Glycoprotein | 4 |
Great | 4 |
Greyhound | 4 |
H3N2 | 4 |
Interferons | 4 |
NETs | 4 |
Ireland | 4 |
Nie | 4 |
Method | 4 |
Metzenbaum | 4 |
Ministry | 4 |
Mission | 4 |
Moore | 4 |
Multiple | 4 |
N95 | 4 |
NFB | 4 |
NG | 4 |
NSs | 4 |
Neurologic | 4 |
Nguyen | 4 |
Non | 4 |
Ivermectin | 4 |
Notes | 4 |
Nursing | 4 |
O. | 4 |
O2 | 4 |
ORF1a | 4 |
ORF3a | 4 |
ORF8 | 4 |
Old | 4 |
Omalizumab | 4 |
Optimal | 4 |
Ortiz | 4 |
Enserink | 4 |
Mepolizumab | 4 |
Mass | 4 |
Marrow | 4 |
Market | 4 |
JH | 4 |
JR | 4 |
Jiang | 4 |
KO | 4 |
King | 4 |
Ksiazek | 4 |
LE | 4 |
LERS | 4 |
LTs | 4 |
LVW | 4 |
LYM | 4 |
Laurent | 4 |
Left | 4 |
Leung | 4 |
Liang | 4 |
Liao | 4 |
Life | 4 |
Lin | 4 |
Ltd | 4 |
MAA | 4 |
MCT | 4 |
MDA-5 | 4 |
MDS | 4 |
Magnesia | 4 |
Marek | 4 |
Environmental | 4 |
BPI | 4 |
Encephalopathy | 4 |
Bernhard | 4 |
Assembly | 4 |
Astra | 4 |
Atrial | 4 |
Australian | 4 |
BALB | 4 |
Babylog | 4 |
Barr | 4 |
Base | 4 |
Based | 4 |
Bassett | 4 |
Becton | 4 |
Bernard | 4 |
Betacoronavirus | 4 |
Ascites | 4 |
Biobank | 4 |
Bonferroni | 4 |
Braun | 4 |
Britain | 4 |
Brucella | 4 |
Burden | 4 |
CAC | 4 |
CCL3 | 4 |
CD24 | 4 |
CD24Fc | 4 |
CD38 | 4 |
CE | 4 |
Asian | 4 |
Arthritis | 4 |
Emerg | 4 |
Ad5-nCoV | 4 |
Overview | 4 |
-8 | 4 |
-80 | 4 |
-defensins | 4 |
6h | 4 |
ABP | 4 |
ACVIM | 4 |
ADCC | 4 |
AL | 4 |
ALGO-1 | 4 |
Acid | 4 |
Acquired | 4 |
Ag | 4 |
Area | 4 |
Agents | 4 |
Air | 4 |
Alberto | 4 |
Alessandra | 4 |
Alzheimer | 4 |
Amanat | 4 |
Amphotericin | 4 |
Anopheles | 4 |
Anosmia | 4 |
Antimicrobial | 4 |
Antithrombin | 4 |
Approval | 4 |
COMFORT | 4 |
CONT | 4 |
CPPV | 4 |
Dermatitis | 4 |
Cytokines | 4 |
DA | 4 |
DEFA3 | 4 |
DEFB1 | 4 |
DHCA | 4 |
DHODH | 4 |
DL | 4 |
DMS | 4 |
DRB1 | 4 |
DV | 4 |
Declaration | 4 |
Defensins | 4 |
Dextran-70 | 4 |
CR | 4 |
Dickinson | 4 |
Dobutamine | 4 |
Dog | 4 |
Dynamics | 4 |
EBV | 4 |
ECAD | 4 |
EE | 4 |
EIA | 4 |
EMERGENCY | 4 |
EU | 4 |
Effort | 4 |
Egger | 4 |
Cu | 4 |
Cryo | 4 |
Crs | 4 |
Crit | 4 |
CROWN | 4 |
CSU | 4 |
California | 4 |
Calmette | 4 |
Cardiology | 4 |
Carlos | 4 |
Cefotaxim | 4 |
Chan | 4 |
Chemokine | 4 |
Chemotherapy | 4 |
Chiang | 4 |
Chikungunya | 4 |
Christmas | 4 |
Chu | 4 |
Chun | 4 |
Class | 4 |
Cluster | 4 |
Co. | 4 |
Cocker | 4 |
Cohen | 4 |
Collie | 4 |
Communicable | 4 |
Comorbidity | 4 |
Correlation | 4 |
Coxiella | 4 |
Outbreak | 4 |
MCP1 | 4 |
Oxygen | 4 |
hypoalbuminemia | 4 |
fedratinib | 4 |
fowleri | 4 |
ger | 4 |
glucosuria | 4 |
haemodialysis | 4 |
heparinized | 4 |
hmg | 4 |
hs | 4 |
hydrolase | 4 |
hypercoagulopathy | 4 |
hyperinflammatory | 4 |
hypnozoites | 4 |
hypoproteinemia | 4 |
famotidine | 4 |
iNO | 4 |
ibritumomab | 4 |
influenza | 4 |
intensivists | 4 |
interactome | 4 |
interleukin-1 | 4 |
iris | 4 |
ketoacids | 4 |
l. | 4 |
lambda | 4 |
leiomyosarcoma | 4 |
leucopaenia | 4 |
favipiravir | 4 |
falciparum | 4 |
alefacept | 4 |
chemoattractant | 4 |
amebic | 4 |
ammatory | 4 |
angiomatosis | 4 |
artemether | 4 |
artemetherelumefantrine | 4 |
bacillary | 4 |
bacteriuria | 4 |
beta-1b | 4 |
bis | 4 |
burgdorferi | 4 |
carina | 4 |
cetuximab | 4 |
confi | 4 |
factorII | 4 |
conorii | 4 |
cortex | 4 |
dP | 4 |
das | 4 |
defi | 4 |
dihydroartemisinin | 4 |
disease-2019 | 4 |
drug | 4 |
dysfunction | 4 |
enoxaparin | 4 |
ex | 4 |
extravascular | 4 |
lo | 4 |
longicornis | 4 |
ltration | 4 |
stranguria | 4 |
polyphagia | 4 |
portosystemic | 4 |
pp1a | 4 |
pp1ab | 4 |
prednisone | 4 |
pseudotyped | 4 |
receptor-1 | 4 |
rhinorrhea | 4 |
sars | 4 |
scapularis | 4 |
siRNA | 4 |
specifi | 4 |
subplate | 4 |
lumefantrine | 4 |
sucralfate | 4 |
sulfamethoxazole | 4 |
tachyarrhythmias | 4 |
tacrolimus | 4 |
thromboelastography | 4 |
uPA | 4 |
vasculopathy | 4 |
virologic | 4 |
zona | 4 |
~g | 4 |
λ | 4 |
P.D. | 4 |
phi | 4 |
peak | 4 |
parasitaemia | 4 |
panitumumab | 4 |
mAbs | 4 |
mefloquine | 4 |
megakaryocyte | 4 |
melioidosis | 4 |
meningitidis | 4 |
meplazumab | 4 |
metapneumovirus | 4 |
methemoglobin | 4 |
metronidazole | 4 |
myalgia | 4 |
myoglobinuria | 4 |
n=10 | 4 |
n=16 | 4 |
nafamostat | 4 |
nd | 4 |
nick | 4 |
nite | 4 |
non | 4 |
nov | 4 |
novo | 4 |
orthotopic | 4 |
os | 4 |
p=0.002 | 4 |
p=0.035 | 4 |
pO2 | 4 |
als | 4 |
syndromic | 4 |
ageusia | 4 |
SARI | 4 |
Renin | 4 |
Respir | 4 |
Reverse | 4 |
Rhesus | 4 |
≥ | 4 |
Rhinovirus | 4 |
Richard | 4 |
Rickettsiae | 4 |
Roe | 4 |
Rolando | 4 |
S5 | 4 |
SAE | 4 |
SARS3a | 4 |
Recumbent | 4 |
SCCM | 4 |
SSCP | 4 |
SSTI | 4 |
STATA | 4 |
Salvador | 4 |
Sci | 4 |
Sciences | 4 |
Score | 4 |
Seafood | 4 |
Seattle | 4 |
Secondary | 4 |
Septic | 4 |
Red | 4 |
RDT | 4 |
Silver | 4 |
Pediatr | 4 |
P1CU | 4 |
Zhu | 4 |
P=0.001 | 4 |
PAP | 4 |
PEE | 4 |
PMNL | 4 |
PVR | 4 |
Pa02 | 4 |
Pablo | 4 |
Pathways | 4 |
Paula | 4 |
Paw | 4 |
Peritoneal | 4 |
RCTs | 4 |
Pinto | 4 |
Position | 4 |
Post | 4 |
Presymptomatic | 4 |
Prevalence | 4 |
Proceedings | 4 |
Progression | 4 |
Project | 4 |
Qi | 4 |
Qs | 4 |
RAAS | 4 |
RAO | 4 |
Siemens | 4 |
PRISMA | 4 |
Social | 4 |
Vultaggio | 4 |
VI | 4 |
VVHF | 4 |
Vaccines | 4 |
Validation | 4 |
Vascular | 4 |
Venous | 4 |
Ventilation | 4 |
Ventilator | 4 |
Victoria | 4 |
Vincent | 4 |
Volume | 4 |
Voriconazole | 4 |
WMD | 4 |
Upper | 4 |
Weil | 4 |
Wenzhou | 4 |
Wholesale | 4 |
Workshop | 4 |
Wright | 4 |
XDR | 4 |
Xi | 4 |
Xia | 4 |
Xuan | 4 |
Spaniels | 4 |
Zeneca | 4 |
Zealand | 4 |
VAP | 4 |
Xpert | 4 |
Units | 4 |
Targets | 4 |
UKB | 4 |
Springer | 4 |
Standardbred | 4 |
Stability | 4 |
Statement | 4 |
Strategies | 4 |
Spearman | 4 |
Support | 4 |
SvO | 4 |
TG | 4 |
TPN | 4 |
TS | 4 |
Systems | 4 |
Taxonomy | 4 |
Tongji | 4 |
UA | 4 |
Trent | 4 |
Teton | 4 |
Transjugular | 4 |
Tramadol | 4 |
Transmembrane | 4 |
Thoracocentesis | 4 |
Thomas | 4 |
Th-1 | 4 |
Tetralogy | 4 |
HTCC | 3 |
Henderson | 3 |
Hemostatic | 3 |
Handbook | 3 |
Hamburg | 3 |
Haldar | 3 |
Hajj | 3 |
Hageman | 3 |
Haemolysis | 3 |
Hepatology | 3 |
Haemofiltration | 3 |
HBIG | 3 |
HSV | 3 |
HSE | 3 |
HO-1 | 3 |
HNP1 | 3 |
HH | 3 |
HES | 3 |
HCoVs | 3 |
HBx | 3 |
HBs | 3 |
HBcAg | 3 |
HAV | 3 |
Hetastarch | 3 |
Hydrocortisone | 3 |
Heterologous | 3 |
Histopathologic | 3 |
IFN- | 3 |
IFN- | 3 |
HA | 3 |
IEIs | 3 |
IAC | 3 |
I20 | 3 |
I0 | 3 |
Hypoxemia | 3 |
Hypovolemic | 3 |
Hypoplastic | 3 |
Hypomagnesemia | 3 |
Hypocalcemia | 3 |
Hypertonic | 3 |
Hyperinflammatory | 3 |
Hyperferritinemia | 3 |
Hypercapnia | 3 |
Hy | 3 |
Huoshenshan | 3 |
Hui | 3 |
Hs | 3 |
Hound | 3 |
Hospitalization | 3 |
Hodgkin | 3 |
Ho | 3 |
Histopathology | 3 |
HAMA | 3 |
Fulminant | 3 |
H9N2 | 3 |
Exposure | 3 |
Fischer | 3 |
Fig.1 | 3 |
Fie | 3 |
Feng | 3 |
FasL | 3 |
Facility | 3 |
FTY720 | 3 |
FRANCE | 3 |
FIO | 3 |
FFA | 3 |
FA | 3 |
Exoribonuclease | 3 |
GzmB | 3 |
Exchange | 3 |
Evans | 3 |
Eur | 3 |
Eu | 3 |
Epitopes | 3 |
Enteroviruses | 3 |
Endotracheal | 3 |
Endothelial | 3 |
Embase | 3 |
IIb | 3 |
Emapalumab | 3 |
Fluorocytosine | 3 |
Frankfurt | 3 |
Fresh | 3 |
Furosemide | 3 |
Guo | 3 |
Guide | 3 |
Gu | 3 |
Green | 3 |
Greece | 3 |
Graz | 3 |
Grant | 3 |
Gramm | 3 |
Gram | 3 |
Government | 3 |
Goal | 3 |
Gillet | 3 |
Giemsa | 3 |
Giardia | 3 |
Genetics | 3 |
Genes | 3 |
Gelderblom | 3 |
Gastroenterology | 3 |
Gal | 3 |
GOS | 3 |
GINA | 3 |
GI | 3 |
G1764A | 3 |
IFNα | 3 |
Kaletra | 3 |
IL-12p40 | 3 |
LVSF | 3 |
Leukocyte | 3 |
Lei | 3 |
Laura | 3 |
Latin | 3 |
Language | 3 |
Lanadelumab | 3 |
Lamivudine | 3 |
Laboratories | 3 |
Label | 3 |
La | 3 |
LY6E | 3 |
LVEDD | 3 |
IL-12p70 | 3 |
LMV | 3 |
LC | 3 |
LAVOLTA | 3 |
LAMP | 3 |
L7 | 3 |
L1 | 3 |
Kussmaul | 3 |
Kirk | 3 |
Kinase | 3 |
Kim | 3 |
Kathleen | 3 |
Level | 3 |
Lig | 3 |
Like | 3 |
Literature | 3 |
Eli | 3 |
Maggi | 3 |
Macaque | 3 |
Macaca | 3 |
MPAP | 3 |
MMR | 3 |
MLST | 3 |
ML | 3 |
MIP-1β | 3 |
MHG | 3 |
MHE | 3 |
MESO | 3 |
MDT | 3 |
MC | 3 |
MBL-2 | 3 |
MAT | 3 |
Lymphoid | 3 |
Luo | 3 |
Lucia | 3 |
Louis | 3 |
Lombardia | 3 |
Local | 3 |
Lo | 3 |
Jose | 3 |
Johns | 3 |
Jin | 3 |
Immunoassay | 3 |
Imbalanced | 3 |
Ignacio | 3 |
IgG3 | 3 |
Ig | 3 |
Identifi | 3 |
ITK | 3 |
ITAO | 3 |
ISGs | 3 |
ISG | 3 |
IRF | 3 |
IRB | 3 |
IPPV | 3 |
IP10 | 3 |
IO | 3 |
INO-4800 | 3 |
IMPDH | 3 |
ILC3 | 3 |
ILC2s | 3 |
ILC1 | 3 |
IL8 | 3 |
IL-1 | 3 |
IL-1R1 | 3 |
IL-16 | 3 |
Immunization | 3 |
Immunohistochemical | 3 |
Ji | 3 |
Immunohistochemistry | 3 |
Jews | 3 |
Jacob | 3 |
JM | 3 |
JL | 3 |
JKF | 3 |
Israel | 3 |
Interventions | 3 |
Intercellular | 3 |
Inspiratory | 3 |
Initial | 3 |
Inhaled | 3 |
Infrared | 3 |
Informed | 3 |
Inflammasome | 3 |
Inflammaging | 3 |
Infected | 3 |
Infasurf | 3 |
Indian | 3 |
Incubation | 3 |
Inc | 3 |
Immunotherapy | 3 |
Immunomodulatory | 3 |
Immunological | 3 |
Elsevier | 3 |
C3a | 3 |
El | 3 |
Babinski | 3 |
Bedfont | 3 |
Beatriz | 3 |
Basis | 3 |
Basiliximab | 3 |
Basel | 3 |
Barré | 3 |
Baragwanath | 3 |
Bangladesh | 3 |
Baltimore | 3 |
Bai | 3 |
Bahia | 3 |
BUN/2.8 | 3 |
CD | 3 |
BOOP | 3 |
BMD | 3 |
BA | 3 |
B*0703 | 3 |
Azotemia | 3 |
Azole | 3 |
Autoimmune | 3 |
Auscultate | 3 |